A practical guide for Life Sciences teams facing unsustainable document volumes — and the tested path to 60–80% time savings through automation.
"Two years ago, with three documents per day, it was fine. Now we're at ten. We expect 30% growth next year — it's not going to work."
The volume of information and documents that Life Sciences teams need to manage keeps growing faster than headcount. When a new facility is commissioned or several team members are away at the same time, the pain is particularly acute. Certificates of Analysis, Laboratory Reports, Stability Studies, Toxicology Summaries, Supplier Assessments, SOPs — so much of the work in this industry flows through documents, and someone has to review, extract, and act on every one of them, under time pressure and very high quality standards.
Here is the reality of human capacity: a skilled reviewer can efficiently process 30,000 to 50,000 pages per year — roughly 150 to 250 per day depending on content density. That is for reviewing and archiving with basic cleaning, not for turning content into structured, business-usable data. High-volume teams face 100,000+ pages per year, sometimes millions. The arithmetic does not work.
This article is a tribute to the teams carrying those loads — absorbing peak volumes late at night, finding workarounds, making it work through sheer effort. There is a better way. Not magic: a tested, incremental process to build reliable document automation that saves 60 to 80% of processing time, with full traceability and quality standards that auditors can trust.
In this article
When document volumes grow, organisations have three options: scale their internal team, outsource to a specialist provider, or automate. Each has a rightful place. The mistake is applying the wrong model to the wrong problem — and the most common mistake in Life Sciences is defaulting to headcount when volume is the actual issue.
The table below compares the three approaches at a meaningful scale: 30,000 documents per year totalling approximately 300,000 pages — a realistic figure for a mid-sized pharmaceutical or CDMO company with a combination of internal production and external suppliers or testing.
30,000 Documents / Year — Cost and Capability Comparison
| Internal Team | External / Outsourced | ML Automation | |
|---|---|---|---|
| Onboarding | Weeks per FTE | Weeks per FTE | Weeks per model |
| Team required | 6–7 FTEs full time | 6–10 FTEs (provider side) | 1–2 reviewers, part time |
| Data capture depth | Top 5 fields per document | Top 5–10 fields per document | 10–20× more data points |
| Data control | High | Average | Very high |
| Standardisation | High | Average | Very high |
| Cycle speed | Variable — backlogs and bottlenecks | Days to weeks | Minutes |
| Estimated annual cost (European mid-size company) | ~€800k | €500–600k | €150–200k |
| Best suited for | Variable content, judgment calls, novel document types | One-off projects, frequent scope changes | Scaling volumes, standardised outputs, repetitive document types |
A few observations worth highlighting. First, the cost differential compounds with volume — at 30,000 documents/year, automation already saves €350–650k annually versus internal processing. At 100,000 documents, the case is overwhelming. Second, outsourcing does not solve the problem: it reduces cost modestly but introduces dependency, data security exposure, and typically lower standardisation. Third, and most importantly: automation does not require a perfect document landscape to get started. Different layouts across suppliers are fine — what matters is consistent content logic within a document type.
Where internal teams and human reviewers remain essential is for the judgment-heavy exceptions: documents with unusual structures, ambiguous values, or content that sits outside the trained model's confidence threshold. The right architecture routes these automatically to human review — keeping experts focused on the cases that actually need them.
Document processing time varies enormously by content density. A Certificate of Analysis takes 10–15 minutes to review and log. A Stability Report or Clinical Study can take 4–6 hours. What is less obvious is that the hidden cost of interruption, context switching, and rework inflates actual time by roughly 30% above direct review time — something most workload models systematically underestimate.
The table below runs a simple calculation across two representative document types. The numbers are conservative.
Annual Resource Cost and Automation Savings Estimate
| Average-density documents (e.g. CoAs, Lab Results) |
High-density documents (e.g. Stability Reports, Studies) |
|
|---|---|---|
| Documents per year | 20,000 | 1,000 |
| Average review time per document | 15 minutes | 5 hours |
| Direct review time (total) | 5,000 hrs | 5,000 hrs |
| Add 30% for interruptions and rework | +1,650 hrs | +1,650 hrs |
| Total actual resource consumed | 6,650 hrs | 6,650 hrs |
| Hours saved at 80% automation | ~5,300 hrs | ~5,300 hrs |
This is not theoretical. The 80% savings figure reflects what well-configured automation achieves on high-repetition document types with standardisable output — CoAs from known suppliers, lab result formats used across a product portfolio, recurring stability timepoints. For more heterogeneous or judgment-heavy documents, realistic savings are 50–65%, still highly material. The key question is not whether savings exist — it is whether your document types meet the conditions for reliable automation.
Want to run the numbers for your specific volumes?
Get a call back →The conditions for reliable document automation are straightforward. You need high volume of similar document types — layout variation across suppliers or templates is acceptable, but the underlying information logic must be somewhat consistent — and a standardisable output: defined fields, controlled vocabulary, agreed formats. If both conditions are met, automation is appropriate.
CoAs, Lab Results, Supplier Qualification Questionnaires, Stability Summaries, and Batch Records all qualify. Highly narrative, case-specific expert reports typically do not — at least not for standardisable extraction. It's also possible to run both: automation for the structured portions, expert review for the interpretive sections.
Start small, scale from there.
Define what information has value as you go through the documents.
The first model will not be perfect. That is expected and fine.
Each cycle compounds quality. Each doubling reduces the marginal review burden.
The value of extraction is only realised when the data flows to where decisions are made.
The document volume problem in Life Sciences is not going away. If anything, it grows with every new supplier, every new market, every new product. The teams that will handle this best are not those with the largest headcount — they are those that have built reliable automation for the repetitive work and reserved expert attention for the cases that genuinely require it.
There is no magic here. The 60–80% time savings we see in production deployments come from a disciplined process: start small, annotate carefully, scale in doublings, maintain lineage. It takes a few weeks to build a first production-ready model for a well-defined document type. It takes a few months to have a suite of models covering the core of a document portfolio. And once built, it runs continuously — absorbing volume growth without proportional cost growth.
For the teams absorbing peak loads today: this path exists, it is tested, and it is closer than it might look.
Want to assess whether your document types are ready for automation?
Acodis works with pharmaceutical and life sciences companies to build production-grade document automation — with full traceability, GxP-compatible audit trails, and measurable ROI.
Book a free 30-minute consultation →